• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine

tetano

Editor, Senior Moderator
Int J Pharm. 2016 Aug 11. pii: S0378-5173(16)30762-1. doi: 10.1016/j.ijpharm.2016.08.022. [Epub ahead of print]
[h=1]A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine.[/h] Kanojia G[SUP]1[/SUP], Willems GJ[SUP]2[/SUP], Frijlink HW[SUP]3[/SUP], Kersten GF[SUP]4[/SUP], Soema PC[SUP]5[/SUP], Amorij JP[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Spray dried vaccine formulations might be an alternative to traditional lyophilized vaccines. Compared to lyophilization, spray drying is a fast and cheap process extensively used for drying biologicals. The current study provides an approach that utilizes Design of Experiments for spray drying process to stabilize whole inactivated influenza virus (WIV) vaccine. The approach included systematically screening and optimizing the spray drying process variables, determining the desired process parameters and predicting product quality parameters. The process parameters inlet air temperature, nozzle gas flow rate and feed flow rate and their effect on WIV vaccine powder characteristics such as particle size, residual moisture content (RMC) and powder yield were investigated. Vaccine powders with a broad range of physical characteristics (RMC 1.2-4.9%, particle size 2.4-8.5μm and powder yield 42-82%) were obtained. WIV showed no significant loss in antigenicity as revealed by hemagglutination test. Furthermore, descriptive models generated by DoE software could be used to determine and select (set) spray drying process parameter. This was used to generate a dried WIV powder with predefined (predicted) characteristics. Moreover, the spray dried vaccine powders retained their antigenic stability even after storage for 3 months at 60?C. The approach used here enabled the generation of a thermostable, antigenic WIV vaccine powder with desired physical characteristics that could be potentially used for pulmonary administration.
Copyright ? 2016. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] Nozzle gas flow rate; Process optimization; Process parameters; Quality by design; Spray drying

PMID: 27523619 DOI: 10.1016/j.ijpharm.2016.08.022
[PubMed - as supplied by publisher]
 
Back
Top Bottom